Background: Phenotypes of eosinophilic esophagitis (EoE) are not well-characterized.
Objective: To describe clinical features of patients with EoE with predefined phenotypes, determine predictors of these phenotypes, and make inferences about the natural history of EoE.
Design: Retrospective study.
Setting: Tertiary-care center.
Patients: Incident EoE cases from 2001 to 2011 that met consensus diagnostic guidelines.
Intervention: Review of records.
Main Outcome Measurements: Endoscopic phenotypes, including fibrostenotic, inflammatory, or mixed. Other groups of clinical characteristics examined included atopy, level of esophageal eosinophilia, and age of symptom onset. Multinomial logistic regression assessed predictors of phenotype status.
Results: Of 379 cases of EoE identified, there were no significant phenotypic differences by atopic status or level of eosinophilia. Those with the inflammatory phenotype were more likely to be younger than those with mixed or fibrostenotic (13 vs 29 vs 39 years, respectively; P < .001) and less likely to have dysphagia, food impaction, and esophageal dilation (P < .001 for all). The mean symptom length before diagnosis was shorter for inflammatory (5 vs 8 vs 8 years; P = .02). After multivariate analysis, age and dysphagia independently predicted phenotype. The odds ratio (OR) for fibrostenosis for each 10-year increase in age was 2.1 (95% CI, 1.7-2.7). The OR for dysphagia was 7.0 (95% CI, 2.6-18.6).
Limitations: Retrospective, single-center study.
Conclusion: In this large EoE cohort, the likelihood of fibrostenotic disease increased markedly with age. For every 10-year increase in age, the odds of having a fibrostenotic EoE phenotype more than doubled. This association suggests that the natural history of EoE is a progression from an inflammatory to a fibrostenotic disease.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599711 | PMC |
http://dx.doi.org/10.1016/j.gie.2013.10.027 | DOI Listing |
Am J Gastroenterol
January 2025
Kennth C. Griffin Esophageal Center, Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Heliyon
December 2024
Department of Gastroenterology, IRCCS Humanitas Research Hospital, 20089 Rozzano, Milan, Italy.
Fibrosis is the pathological consequence of chronic inflammation. In Crohn's disease (CD), fibrostenotic complications occur with 50-70 % frequency as a failure to properly repair the tissue damage. Intestinal stenosis requires surgical intervention and relapses in most patients.
View Article and Find Full Text PDFDig Dis Sci
December 2024
Division of Gastroenterology & Hepatology, Department of Medicine, Center for Esophageal Diseases and Swallowing, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Background: Predicting fibrostenotic complications prior to endoscopy in eosinophilic esophagitis (EoE) is challenging and esophageal strictures and narrowing are commonly missed on endoscopy.
Aim: To develop and validate a score to predict fibrostenosis in EoE patients prior to endoscopy.
Methods: We leveraged a large database of newly diagnosed EoE patients.
Cureus
November 2024
Gastroenterology and Hepatology, Sheikh Shakhbout Medical City, Abu Dhabi, ARE.
J Imaging
November 2024
Department of Medical & Surgical Sciences, Section of Diagnostic Imaging, University of Foggia, Viale Luigi Pinto n. 1, 71122 Foggia, Italy.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!